The "List of Guidances for Statistics in Regulatory Affairs" typically refers to a compilation of documents and guidelines provided by regulatory agencies that address statistical methods and best practices for the design, analysis, and interpretation of clinical trials and other research studies in the context of drug and device approval. These guidelines are essential to ensure that statistical analyses meet the necessary standards to support regulatory submissions.
Articles by others on the same topic
There are currently no matching articles.